The present invention is directed to pyrrolidine compounds of formula (I) (wherein R?1, R2, R3, R4, R5, R6, R14¿ and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3.
本发明涉及式(I)的
吡咯烷化合物(其中R1,R2,R3,R4,R5,R6,R14和n在此定义),其作为
趋化因子受体活性调节剂具有用途。特别地,这些化合物作为
趋化因子受体CCR-5和/或CCR-3的调节剂具有用途。